Singapore – September 11, 2026 -- Parseur, an AI-powered document processing platform serving more than 10,000 businesses globally, has achieved SOC 2 Type II compliance following an independent audit by Constellation GRC, verified through Oneleet.
New York – September 11, 2026 -- Monteverde & Associates PC has opened investigations into four pending mergers, questioning whether shareholders of Bio-Techne, Caesars Entertainment, Colony Bankcorp and Auddia are receiving fair value under the proposed deal terms.
Berlin – September 11, 2026 -- Germany's Federal Medical Association (Bundesärztekammer) has confirmed support for a cross-sector reform of acute and emergency care, while pushing for amendments before the bill clears parliament.
San Diego – September 11, 2026 -- Shareholder rights firm Robbins LLP has filed a class action against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) on behalf of investors who purchased the biotech's securities between December 29, 2025 and June 29, 2026, after the FDA rejected the company's kidney disease drug for a second time over unresolved manufacturing deficiencies.
Berlin – September 11, 2026 -- The OECD's PISA 2025 study released today shows Germany's reading and math scores continuing to decline, prompting the SPD parliamentary group to push for expanded funding of its Startchancen-Programm and a new early-childhood quality law.
San Diego – September 11, 2026 -- Investors who purchased UWM Holdings Corporation (NYSE: UWMC) securities between March 9, 2026 and August 5, 2026 have until October 13, 2026 to seek lead plaintiff status in a securities fraud class action filed against the mortgage lender.
Hangzhou – September 11, 2026 -- HEVI Corp., a wholly owned subsidiary of Greenland Technologies Holding Corporation (NASDAQ: GTEC), has secured approval from the New York Vehicle Inspection Program (NYVIP) for two of its heavy electric industrial vehicles, opening access to state purchase incentives.
Cambridge, Massachusetts – September 11, 2026 -- Harbour BioMed (HKEX: 02142) and partner Windward Bio reported positive Phase 2 interim results for HBM9378/WIN378, a twice-yearly TSLP-blocking antibody, from the 147-patient POLARIS-1 asthma trial, clearing the path for two Phase 3 studies.
Houston – September 11, 2026 -- Cloverleaf Infrastructure LLC has signed the Michigan Affordability and Responsible Growth Pledge, joining Anthropic, Google, Microsoft, OpenAI and Oracle as signatories to the state's data center development framework.
Enschede -- Bizzdesign GovCloud achieved FedRAMP Certification on September 1, 2026, clearing the way for U.S. federal agencies to adopt the enterprise transformation SaaS provider's dedicated government offering.
